Abstract
Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease.
Keywords: Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease
Mini-Reviews in Medicinal Chemistry
Title: Low Molecular Weight Inhibitors of the Protease Anthrax Lethal Factor
Volume: 8 Issue: 3
Author(s): Georgios A. Spyroulias, Georgios A. Dalkas, Athanasios Papakyriakou and Alexios Vlamis-Gardikas
Affiliation:
Keywords: Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease
Abstract: Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease.
Export Options
About this article
Cite this article as:
Spyroulias A. Georgios, Dalkas A. Georgios, Papakyriakou Athanasios and Vlamis-Gardikas Alexios, Low Molecular Weight Inhibitors of the Protease Anthrax Lethal Factor, Mini-Reviews in Medicinal Chemistry 2008; 8 (3) . https://dx.doi.org/10.2174/138955708783744083
DOI https://dx.doi.org/10.2174/138955708783744083 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemical and Structural Diversity of siRNA Molecules
Current Topics in Medicinal Chemistry Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry The Antimitotic Potential of PARP Inhibitors, An Unexplored Therapeutic Alternative
Current Topics in Medicinal Chemistry Induction of Propranolol Metabolism by Ginkgo biloba Extract EGb 761 in Rats
Current Drug Metabolism Follicular Cysts: A Single Sign and Different Diseases. A View from Comparative Medicine
Current Pharmaceutical Design A Series of Novel Neuroprotective Blood Brain Barrier Penetrating Flavonoid Drugs to Treat Acute Ischemic Stroke
Current Pharmaceutical Design Characterization of Heme Oxygenase in Adult Rodent Platelets
Current Neurovascular Research The SCF-type E3 Ubiquitin Ligases as Cancer Targets
Current Cancer Drug Targets Gastrointestinal Hemorrhage is Associated with Mortality after Acute Ischemic Stroke
Current Neurovascular Research Between Bench and Bed Side: PI3K Inhibitors
Current Molecular Pharmacology Effects of a Long-Term Treatment with an Antioxidant Pyridoindole on Vascular Responsiveness in Diabetes-Induced Aging Rats
Current Aging Science Novel 4- Aryl-2(1H)-phthalazinone Derivatives as Cyclooxygenase-2 Inhibitors: Synthesis, Molecular Modeling Study and Evaluation as Promising Anti-inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Calcium Channel Subtypes and Exocytosis in Chromaffin Cells at Early Life
Current Molecular Pharmacology Medical Implants as Delivery Platforms for Tissue Engineering and Regenerative Medicine Applications
Current Tissue Engineering (Discontinued) Screening of Enzyme Inhibitors from Traditional Chinese Medicine
Combinatorial Chemistry & High Throughput Screening Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy
Current Medicinal Chemistry Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Topics in Medicinal Chemistry Animal Models of Carcinogenesis in Inflamed Colorectum: Potential Use in Chemoprevention Study
Current Drug Targets Antimicrobial Peptides in Burns and Wounds
Current Protein & Peptide Science Self-Assembly of DNA and Cell-Adhesive Proteins onto pH-Sensitive Inorganic Crystals for Precise and Efficient Transgene Delivery
Current Pharmaceutical Design